Axcelis-Veeco Merger Closing Pushed to End of Q1 2027 on New HSR Filing
ACLS sits 38% above its 52-week low of $73.6.
Summary
Axcelis and Veeco pushed the expected closing of their all-stock merger to the end of Q1 2027, citing pending SAMR approval and the need for a new HSR filing as the current clearance expires. Deal terms are unchanged at 0.3575 Axcelis shares per Veeco share.
Key Events · M&A and Partnerships · ACLS
-
Merger Closing Delayed to Q1 2027
Axcelis and Veeco now expect their all-stock merger to close by the end of the first quarter of 2027, subject to satisfaction or waiver of all closing conditions.
-
New HSR Submission Required
The current HSR Act clearance is expiring, so the parties plan to promptly make a new submission, and closing is conditioned on expiration or early termination of that new waiting period.
-
China SAMR Approval Still Pending
Completion remains subject to pending regulatory approval from China's State Administration for Market Regulation; the parties say they continue to work constructively with SAMR.
-
Deal Terms Unchanged
Each Veeco share still converts into 0.3575 Axcelis shares at closing, so the exchange ratio and economics of the transaction are not affected by the delay.
Analysis · ACLS · Technology
The all-stock merger with Veeco will take longer than previously expected. Axcelis now targets closing by the end of the first quarter of 2027, and because the current HSR antitrust clearance is expiring, the parties must make a new HSR submission and wait out a fresh waiting period. China's SAMR approval is still outstanding. For holders, the deal consideration is unchanged at 0.3575 Axcelis shares per Veeco share, but the delay extends the period of uncertainty and integration risk, and each new regulatory step is a chance for the timetable to slip again.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ACLS was trading at $101.75 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $73.60 to $193.78. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.